PWM
TXG icon

Perigon Wealth Management’s 10x Genomics TXG Stock Holding History

Perigon Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$283K Buy
+7,371
New +$193K ﹤0.01% 1153
2024
Q4 		– Sell
-16,537
Closed -$373K – 1101
2024
Q3 		$373K Buy
16,537
+3,784
+30% +$78.2K 0.01% 706
2024
Q2 		$248K Sell
12,753
-1,415
-10% -$37.1K 0.01% 756
2024
Q1 		$532K Buy
14,168
+4,512
+47% +$198K 0.02% 516
2023
Q4 		$540K Buy
9,656
+1,818
+23% +$79.1K 0.02% 476
2023
Q3 		$323K Sell
7,838
-2,593
-25% -$135K 0.01% 559
2023
Q2 		$582K Buy
10,431
+81
+0.8% +$4.38K 0.02% 421
2023
Q1 		$577K Buy
10,350
+140
+1% +$6.54K 0.03% 369
2022
Q4 		$372K Buy
10,210
+3,044
+42% +$99.5K 0.02% 464
2022
Q3 		$204K Buy
7,166
+408
+6% +$15.5K 0.02% 543
2022
Q2 		$306K Buy
6,758
+1,541
+30% +$80K 0.03% 426
2022
Q1 		$397K Buy
5,217
+1,331
+34% +$116K 0.03% 407
2021
Q4 		$579K Buy
3,886
+1,600
+70% +$245K 0.04% 310
2021
Q3 		$333K Buy
2,286
+109
+5% +$18.7K 0.03% 392
2021
Q2 		$426K Buy
2,177
+28
+1% +$5.07K 0.04% 340
2021
Q1 		$389K Buy
2,149
+670
+45% +$116K 0.04% 341
2020
Q4 		$209K Buy
+1,479
New +$215K 0.02% 385

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Perigon Wealth Management's TXG Position: Q2 2026 in Review

Perigon Wealth Management opened a new position in 10x Genomics (TXG) in Q2 2026: 7,371 shares worth $283K. The stake represents ﹤0.01% of the portfolio and ranks #1153 among its holdings. This is a return to the name: Perigon Wealth Management previously reported a position in TXG as recently as Q3 2024.

Perigon Wealth Management first reported a position in TXG in Q4 2020 and has held it in 17 quarters since. The position peaked at $582K in Q2 2023. 392 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Perigon Wealth Management held 7,371 shares of 10x Genomics worth $283K as of Q2 2026.
  • 10x Genomics was a new Perigon Wealth Management position in Q2 2026.
  • 10x Genomics made up ﹤0.01% of Perigon Wealth Management's portfolio in Q2 2026, its #1153 holding.
  • Perigon Wealth Management first reported a position in 10x Genomics in Q4 2020 and has held it in 17 quarters since.
  • Perigon Wealth Management's 10x Genomics position peaked at $582K in Q2 2023.
  • 392 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Perigon Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.